dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp05054

General Description

Peptide name : P2

Source/Organism : Ceropin A-African clawed frog

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : KWKLFKKIGIGKFLHSATTF

Peptide length: 20

C-terminal modification: Linear

N-terminal modification : Amidation

Non-natural peptide information: None

Activity Information

Assay type : MTT/MTS assay

Assay time : 72h

Activity : IC50 : 47.7 µM

Cell line : NCI-H146

Cancer type : Lung cancer

Other activity : Hemolytic activity

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 2350.8434 Dalton

Aliphatic index : 0.83

Instability index : -8.825

Hydrophobicity (GRAVY) : 0.01

Isoelectric point : 10.602

Charge (pH 7) : 4.8423

Aromaticity : 0.2

Molar extinction coefficient (cysteine, cystine): (5500, 5500)

Hydrophobic/hydrophilic ratio : 1.22222222

hydrophobic moment : -0.254

Missing amino acid : C,R,Q,P,M,E,D,Y,N,V

Most occurring amino acid : K

Most occurring amino acid frequency : 5

Least occurring amino acid : W

Least occurring amino acid frequency : 1

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0.4, 0.1, 0.5)

SMILES Notation: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)[C@@H](C)O

Secondary Structure :

Method Prediction
GOR HHHHHHHHHHEEEEHTTCEE
Chou-Fasman (CF) HHHHHHEEEEHHHHHEECCC
Neural Network (NN) HHHHHHCCCCCEEECCCCCC
Joint/Consensus HHHHHHCCCCCEEECCCCCC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 9352466

Uniprot : Not available

PDB : Not available

CancerPPD : Click here

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Shin SY, et al. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J Pept Res. 1997; 50:279-85. doi: 10.1111/j.1399-3011.1997.tb01469.x

Literature

Paper title : Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.

Doi : https://doi.org/10.1111/j.1399-3011.1997.tb01469.x

Abstract : The hybrid peptide (CA-ME) derived from cecropin A(1-8) and melittin (1-12) has potent antibacterial and antimalarial activities. Because the N-terminal sequence 1-12 of magainin 2 is similar to melittin(1-12), CA-MA with CA(1-8) and MA(1-12) and their analogues were designed and synthesized. Antitumor activities of these peptides were evaluated using three small cell lung cancer cell lines. Greater antitumor activity was observed when the residues 16, 18 and 19 of the peptide were hydrophobic (Leu or Val), basic (Lys) and basic (Lys), respectively. The IC50 values of the peptides with the residues were 2 to 4 microM. Residue 12 was related to hemolytic activity rather than antitumor activity. Increase in amphipathicity of P4 enhanced hemolytic activity without significant change in antitumor activity. The alpha-helicity of the peptides in a 30 mM sodium dodecyl sulfate solution was more closely correlated to hemolytic activity than antitumor activity.